Pulmonary Vasculature: A Target for COVID-19.
作者信息
Chen Lingdan, Tang Ruidi, Chen Hongyuan, Huang Yuhang, Yi Shuting, Bai Qianwen, Zhu Yufan, Hong Cheng, Liu Chunli, Zhang Nuofu, Wang Tao
机构信息
The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China and.
Guangzhou Medical University Guangzhou, Guangdong, China.
出版信息
Am J Respir Crit Care Med. 2021 Jan 15;203(2):260-261. doi: 10.1164/rccm.202009-3564LE.
Abstract
摘要
相似文献
1
Pulmonary Vasculature: A Target for COVID-19.肺血管系统：新冠病毒病的一个靶点
Am J Respir Crit Care Med. 2021 Jan 15;203(2):260-261. doi: 10.1164/rccm.202009-3564LE.
2
COVID-19 pneumonia and the pulmonary vasculature: a marriage made in hell.COVID-19 肺炎与肺血管：地狱里的婚姻。
Eur Respir J. 2021 Sep 16;58(3). doi: 10.1183/13993003.00811-2021. Print 2021 Sep.
3
COVID-19 and Cardiovascular Health: This Is a Public Service Announcement.2019冠状病毒病与心血管健康：这是一则公益公告。
J Am Coll Cardiol. 2021 Jan 19;77(2):170-172. doi: 10.1016/j.jacc.2020.11.027.
4
Comparison of RNA In Situ Hybridization and Immunohistochemistry Techniques for the Detection and Localization of SARS-CoV-2 in Human Tissues.RNA 原位杂交与免疫组织化学技术在检测和定位人组织中 SARS-CoV-2 的比较。
Am J Surg Pathol. 2021 Jan;45(1):14-24. doi: 10.1097/PAS.0000000000001563.
5
Cardiovascular system in the sars-CoV-2: impact of therapies.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染中的心血管系统：治疗的影响
J Hypertens. 2021 Jul 1;39(7):1306-1308. doi: 10.1097/HJH.0000000000002860.
6
In Reply - COVID-19, the Female Immune Advantage, and Cardiovascular Impact.回复——2019冠状病毒病、女性免疫优势及心血管影响
Mayo Clin Proc. 2021 Mar;96(3):821-822. doi: 10.1016/j.mayocp.2020.12.020. Epub 2020 Dec 29.
7
COVID-19, the Female Immune Advantage, and Cardiovascular Impact.新型冠状病毒肺炎、女性免疫优势与心血管影响
Mayo Clin Proc. 2021 Mar;96(3):820-821. doi: 10.1016/j.mayocp.2020.12.021. Epub 2020 Dec 29.
8
Pulmonary vasculature in COVID-19: mechanism to monitoring!新冠病毒肺炎中的肺血管系统：从机制到监测！
Korean J Anesthesiol. 2021 Apr;74(2):186-187. doi: 10.4097/kja.20536. Epub 2020 Oct 5.
9
[Cardiovascular system and COVID-19].[心血管系统与新型冠状病毒肺炎]
Turk Kardiyol Dern Ars. 2020 Oct;48(7):635-639. doi: 10.5543/tkda.2020.65204.
10
Cardiovascular effects of SARS-CoV-2 in hamster.
Lab Anim (NY). 2022 Mar;51(3):77. doi: 10.1038/s41684-022-00939-8.
引用本文的文献
1
Acute Pulmonary Embolism in COVID-19: A Potential Connection between Venous Congestion and Thrombus Distribution.新型冠状病毒肺炎中的急性肺栓塞：静脉淤血与血栓分布之间的潜在联系
Biomedicines. 2022 Jun 2;10(6):1300. doi: 10.3390/biomedicines10061300.
2
Pulmonary arterial hypertension and right ventricular systolic dysfunction in COVID-19 survivors.新冠病毒疾病康复者的肺动脉高压和右心室收缩功能障碍
Cardiol J. 2022;29(1):163-165. doi: 10.5603/CJ.a2021.0159. Epub 2021 Dec 13.
3
The need for exercise sciences and an integrated response to COVID-19: A position statement from the international HL-PIVOT network.运动科学的必要性和对 COVID-19 的综合应对：来自国际 HL-PIVOT 网络的立场声明。
Prog Cardiovasc Dis. 2021 Jul-Aug;67:2-10. doi: 10.1016/j.pcad.2021.01.004. Epub 2021 Feb 4.
本文引用的文献
1
Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations.严重 COVID-19 中的肺血管病：生理学、影像学和血液学观察。
Am J Respir Crit Care Med. 2020 Sep 1;202(5):690-699. doi: 10.1164/rccm.202004-1412OC.
2
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.新型冠状病毒肺炎的肺血管内皮细胞炎症、血栓形成和血管生成。
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
3
Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China.中国 COVID-19 患者病情进展相关的纵向血液学和免疫学变化。
J Allergy Clin Immunol. 2020 Jul;146(1):89-100. doi: 10.1016/j.jaci.2020.05.003. Epub 2020 May 11.
4
Endothelial cell infection and endotheliitis in COVID-19.新型冠状病毒肺炎中的内皮细胞感染与内皮炎
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.
5
Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series.组织型纤溶酶原激活物（tPA）治疗 COVID-19 相关急性呼吸窘迫综合征（ARDS）：病例系列。
J Thromb Haemost. 2020 Jul;18(7):1752-1755. doi: 10.1111/jth.14828. Epub 2020 May 11.
6
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
Zotero 插件